Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Biopharmaceutical classification of desloratadine - not all drugs are classified the easy way
ID
Berginc, Katja
(
Author
),
ID
Sibinovska, Nadica
(
Author
),
ID
Žakelj, Simon
(
Author
),
ID
Trontelj, Jurij
(
Author
),
ID
Legen, Igor
(
Author
)
PDF - Presentation file,
Download
(433,79 KB)
MD5: 18AE0182CC80D29C61D58358242F21C5
URL - Source URL, Visit
https://sciendo.com/article/10.2478/acph-2020-0006
Image galllery
Abstract
The biopharmaceutical classification of drugs was designed as a basis for bio-waivers % a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because in vitro permeability and stability assessment can be challenging as shown in this study for desloratadine. Literature shows that desloratadine is highly soluble, while data on luminal stability and permeability are circumstantial. Combined with borderline bioavailability and not really known fraction of absorbed dose, desloratadine was found to be a good example for showing the innovative in vitro approaches necessary to unambiguously classify desloratadine according to Biopharmaceutical Classification System (BCS) guideline. Presented study undoubtedly confirmed that desloratadine solubility is high and dissolution is very rapid for immediate release reference tablets. We have demonstrated desloratadine stability under legally required conditions and also in more physiologically relevant media. High in vitro desloratadine permeability was confirmed using Caco-2 and Parallel Artificial Membrane Permeability Assay (PAMPA). Well-established in vitro model with rat intestinal tissue could not be used due to reasons elaborated in this paper.
Language:
English
Keywords:
desloratadine
,
BCS-based bio-waiver
,
luminal stability
,
permeability
,
dissolution
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2020
Number of pages:
Str. 131-144
Numbering:
Vol. 70, iss. 2
PID:
20.500.12556/RUL-141322
UDC:
544.351.3:615
ISSN on article:
1330-0075
DOI:
10.2478/acph-2020-0006
COBISS.SI-ID:
4797553
Publication date in RUL:
28.09.2022
Views:
627
Downloads:
90
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Acta pharmaceutica
Shortened title:
Acta pharm.
Publisher:
Hrvatsko farmaceutsko društvo
ISSN:
1330-0075
COBISS.SI-ID:
13497349
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0189-2018
Name:
Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back